Skip to main content

Advertisement

Table 1 Data sets summary

From: Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas

GEO accession Group Samples Probes Platform
GSE4732_p1 Dave et al. [30] 54 BL, 249 DLBCL 2745 Custom Affymetrix Lympho-Chip
GSE4732_p2 Dave et al. [30] 33 BL, 66 DLBCL 54,675 Affymetrix HG-U133 plus2.0
GSE4475 Hummel et al. [31] 44 mBL, 48 intermediate, 129 non-mBL 22,283 Affymetrix HG-U133A
GSE10172 Klapper et al. [56] 13 mBL, 9 intermediate, 14 non-mBL 22,283 Affymetrix HG-U133A
GSE26673 Piccaluga et al. [57] 13 eBL, 2 HIV-BL 54,675 Affymetrix HG-U133 plus2.0
GSE17189 Deffenbacher et al. [58] 4 HIV-BL, 13 HIV-DLBCL 54,675 Affymetrix HG-U133 plus2.0
  HMDS 41 BL, 206 DLBCL clinically diagnosed 24,526 Illumina WG-DASL Version_3
  HMDS 70 BL, 169 DLBCL clinically diagnosed 29,377 Illumina WG-DASL Version_4
  1. eBL endemic BL, GEO Gene Expression Omnibus, HMDS Haematological Malignancy Diagnostic Service, HIV-BL HIV-related Burkitt lymphoma HIV-DLBCL HIV-related diffuse large B cell lymphoma mBL molecular BL defined in corresponding paper